SMS PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]
SMS PHARMACEUTICALS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹248 Cr | ₹173 Cr | ₹197 Cr | ₹164 Cr | ₹246 Cr | ₹161 Cr | ₹167 Cr | ₹135 Cr |
Expenses | ₹207 Cr | ₹140 Cr | ₹165 Cr | ₹131 Cr | ₹212 Cr | ₹132 Cr | ₹139 Cr | ₹109 Cr |
Operating Income | ₹41 Cr | ₹33 Cr | ₹31 Cr | ₹34 Cr | ₹34 Cr | ₹29 Cr | ₹28 Cr | ₹26 Cr |
Other Income | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr |
Depreciation | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
Profit Before Tax | ₹29 Cr | ₹22 Cr | ₹20 Cr | ₹22 Cr | ₹22 Cr | ₹17 Cr | ₹15 Cr | ₹13 Cr |
Profit After Tax | ₹20 Cr | ₹17 Cr | ₹14 Cr | ₹16 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹9 Cr |
EPS | ₹2.29 | ₹2.15 | ₹1.67 | ₹1.95 | ₹2.04 | ₹1.36 | ₹1.39 | ₹1.10 |
Industry Peers & Returns | 1W | 1M | 1Y |
SMS PHARMACEUTICALS | 1.2% | 12.5% | 30.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -8.3% | 15.9% |
DIVIS LABORATORIES | -1.9% | 8.6% | 55.9% |
CIPLA | -1.3% | -5.5% | -0.1% |
TORRENT PHARMACEUTICALS | -0.5% | -4.2% | 19.3% |
DR REDDYS LABORATORIES | 0.7% | 5.8% | 6.1% |
MANKIND PHARMA | 1.8% | 0.4% | 16.6% |
ZYDUS LIFESCIENCES | 1.9% | 4.8% | -12.7% |
LUPIN | -1.5% | -6.5% | 21.9% |
SMS PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 43.17 % |
Y-o-Y | 0.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹248 Cr | 43.17 | |
Dec2024 | ₹173 Cr | -11.89 | |
Sep2024 | ₹197 Cr | 19.64 | |
Jun2024 | ₹164 Cr | -33.10 | |
Mar2024 | ₹246 Cr | 52.21 | |
Dec2023 | ₹161 Cr | -3.10 | |
Sep2023 | ₹167 Cr | 23.13 | |
Jun2023 | ₹135 Cr | - |
SMS PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 22.87 % |
Y-o-Y | 21.39 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹41 Cr | 22.87 | |
Dec2024 | ₹33 Cr | 5.55 | |
Sep2024 | ₹31 Cr | -6.11 | |
Jun2024 | ₹34 Cr | -0.32 | |
Mar2024 | ₹34 Cr | 15.93 | |
Dec2023 | ₹29 Cr | 4.22 | |
Sep2023 | ₹28 Cr | 6.26 | |
Jun2023 | ₹26 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -14.20 % |
Y-o-Y | 20.18 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 16.44% | -14.20 | |
Dec2024 | 19.16% | 19.82 | |
Sep2024 | 15.99% | -21.54 | |
Jun2024 | 20.38% | 48.98 | |
Mar2024 | 13.68% | -23.83 | |
Dec2023 | 17.96% | 7.54 | |
Sep2023 | 16.7% | -13.70 | |
Jun2023 | 19.35% | - |
SMS PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 17.59 % |
Y-o-Y | 25.10 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹20 Cr | 17.59 | |
Dec2024 | ₹17 Cr | 23.22 | |
Sep2024 | ₹14 Cr | -15.35 | |
Jun2024 | ₹16 Cr | 2.00 | |
Mar2024 | ₹16 Cr | 30.61 | |
Dec2023 | ₹12 Cr | 2.03 | |
Sep2023 | ₹12 Cr | 36.77 | |
Jun2023 | ₹9 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -17.87 % |
Y-o-Y | 23.89 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 8.09 % | -17.87 | |
Dec2024 | 9.85 % | 39.72 | |
Sep2024 | 7.05 % | -29.22 | |
Jun2024 | 9.96 % | 52.53 | |
Mar2024 | 6.53 % | -14.19 | |
Dec2023 | 7.61 % | 5.26 | |
Sep2023 | 7.23 % | 11.06 | |
Jun2023 | 6.51 % | - |
SMS PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 6.51 % |
Y-o-Y | 12.25 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.29 | 6.51 | |
Dec2024 | ₹2.15 | 28.74 | |
Sep2024 | ₹1.67 | -14.36 | |
Jun2024 | ₹1.95 | -4.41 | |
Mar2024 | ₹2.04 | 50.00 | |
Dec2023 | ₹1.36 | -2.16 | |
Sep2023 | ₹1.39 | 26.36 | |
Jun2023 | ₹1.1 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD